English

PLUS ULTRAProduct LaunchesAnthropicClaude

Claude agents discover novel enzyme system and Anthropic launches Claude in Chrome

PLUS ULTRA by Amenoyomi

Anthropic has announced that its AI model, Claude, autonomously discovered a new enzyme system during experiments at the company's newly-launched wet lab. The company stated that the discovery occurred while Claude searched through a massive database of DNA sequences, with human scientists' involvement limited to the initial prompt and subsequent laboratory work.

According to Anthropic, nearly 950 Claude agents worked for approximately 21 hours, processing 210 million tokens, before identifying an unusual repeating pattern in the dataset. This finding, which was flagged for human review, led to the identification of a previously uncharacterized enzyme system found in bacteriophages, a type of virus that infects bacteria. While Anthropic compared the finding's significance to the machinery behind the gene-editing tool CRISPR, the practical applications of the discovery remain unclear.

In a separate development, Anthropic has announced the general availability of "Claude in Chrome." This feature allows Claude to operate within the Google Chrome browser, enabling it to interact with web content. Anthropic aims to expand the utility of Claude for various tasks, including web-based operations.

PLUS ULTRAby Amenoyomi

The autonomous discovery process involved nearly 950 Claude agents processing 210 million tokens over 21 hours to scan a vast database of DNA sequences. The agents identified an unusual repeating pattern within the dataset and flagged it for human review, marking the transition from autonomous digital exploration to targeted scientific analysis.

Once the pattern was flagged, Anthropic's scientists conducted further analysis and wet lab testing to verify the finding. This physical validation confirmed that the identified pattern was a previously uncharacterized enzyme system found in bacteriophages, which are viruses that infect bacteria.

While the practical applications of this enzyme system are not yet determined and remain under study, Anthropic compares the potential of the discovery to the machinery behind the CRISPR gene-editing tool. The early disclosure is intended to demonstrate Claude's utility in scientific research as the company seeks to attract more scientists and expand into domains such as drug discovery.

Sources

  1. Anthropic’s biolab made a discovery it’s comparing to Crispr (The Verge AI, 2026-09-23)
  2. Claudeがブラウザを自律操作する「Claude in Chrome」一般提供 プロンプトインジェクションをどう防ぐ? (ITmedia AI+, 2026-09-24)